The Effect of Thyroxine Treatment Started in the Neonatal Period on Development and Growth of Two-Year-Old Down Syndrome Children: A Randomized Clinical Trial
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
CONTEXT: Young Down syndrome children appear to have a mild form of congenital hypothyroidism that is rarely detected by neonatal screening and usually left untreated. OBJECTIVE: To investigate the effects of thyroxine treatment on development and growth of young Down syndrome children. DESIGN, SETTING, AND PARTICIPANTS: Single-center, randomized, double-blind, 24-month trial (enrollment June 1999 to August 2001) with nationwide recruitment, comparing thyroxine administration with placebo in 196 Down syndrome neonates. INTERVENTION: Neonates were randomly assigned to treatment for 2 yr with either thyroxine (n = 99; initial dose 8 microg/kg) or placebo (n = 97). Daily thyroxine doses were adjusted at regular intervals to maintain plasma TSH in its normal and free T(4) concentrations in its high-normal range. Placebo dose adjustments mirrored those of thyroxine. MAIN OUTCOME MEASURES: The primary outcome was mental and motor development at age 24 months, assessed with the Bayley Scales of Infant Development II. RESULTS: At age 24 months, the developmental testing results of 90 thyroxine-, and 91 placebo-treated children were available for analysis. The thyroxine-treated children had a 0.7-month smaller delay in motor developmental age (95% confidence interval, -1.4 to 0), corresponding to a difference of seven motor developmental index points. The mental developmental age delay was also 0.7 month smaller in the thyroxine group (95% confidence interval, -1.5 to 0.2), but lacked statistical significance. Thyroxine-treated children had greater gains in length (1.1 cm; 95% confidence interval, 0.2 to 2.0) and weight (378 g; 95% confidence interval 55 to 701). CONCLUSIONS: The data of our study provide evidence to support the hypothesis that thyroxine treatment may improve development and growth of young Down syndrome children. Thyroxine treatment should be considered in Down syndrome neonates to maximize their early development and growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
Oerbeck, B., Sundet, K., Kase, B. F., & Heyerdahl, S. (2003) · Pediatrics · doi:10.1542/peds.112.4.923 · Cited by 176
Simoneau-Roy, J., Marti, S., Deal, C., Huot, C., Robaey, P., & Van Vliet, G. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.02.021 · Cited by 123
Lower Neonatal Screening Thyroxine Concentrations in Down Syndrome Newborns
van Trotsenburg, A. S. P., Vulsma, T., van Santen, H. M., Cheung, W., & de Vijlder, J. J. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021303 · Cited by 118
Self-citationCongenital Hypothyroidism: Developmental Outcome in Relation to Levothyroxine Treatment Variables
Heyerdahl, S., & Oerbeck, B. (2003) · Thyroid · doi:10.1089/105072503770867200 · Cited by 73
Cited by
Clinical practice: The care of children with Down syndrome
Weijerman, M. E., & de Winter, J. P. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1253-0 · Cited by 382
Kempers, M. J. E., Lanting, C. I., van Heijst, A. F. J., van Trotsenburg, A. S. P., Wiedijk, B. M., de Vijlder, J. J. M., & Vulsma, T. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0058 · Cited by 109
Self-citationvan Trotsenburg, A. S. P., Heymans, H. S. A., Tijssen, J. G. P., de Vijlder, J. J. M., & Vulsma, T. (2006) · Pediatrics · doi:10.1542/peds.2006-1136 · Cited by 80
Self-citationRevisiting early hypothyroidism screening in infants with Down syndrome
Purdy, I. B., Singh, N., Brown, W. L., Vangala, S., & Devaskar, U. P. (2014) · Journal of Perinatology · doi:10.1038/jp.2014.116 · Cited by 62
Hart, S. J., Visootsak, J., Tamburri, P., Phuong, P., Baumer, N., Hernandez, M., Skotko, B. G., Ochoa‐Lubinoff, C., Liogier D'Ardhuy, X., Kishnani, P. S., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38465 · Cited by 54
Metadata
- Authors
- van Trotsenburg, A. S. P., Vulsma, T., van Rozenburg-Marres, S. L. R., van Baar, A. L., Ridder, J. C. D., Heymans, H. S. A., Tijssen, J. G. P., & de Vijlder, J. J. M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-06
- Volume
- 90
- Issue
- 6
- Pages
- 3304-3311
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2159682860
- Cited by
- 130
- References
- 5
- FWCI
- 7.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.